Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Capital Employed (2016 - 2025)

Traws Pharma's Return on Capital Employed history spans 13 years, with the latest figure at 46.55% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 46.55% for Q4 2025, down 2026.0% from a year ago — trailing twelve months through Dec 2025 was 46.55% (down 2026.0% YoY), and the annual figure for FY2025 was 2.69%, up 889.0%.
  • Return on Capital Employed for Q4 2025 was 46.55% at Traws Pharma, down from 2.57% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.32% in Q4 2021 to a low of 46.55% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 1.02% (2023), against an average of 7.08%.
  • The sharpest move saw Return on Capital Employed plummeted -2499bps in 2024, then surged 2334bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.32% in 2021, then crashed by -83bps to 0.59% in 2022, then crashed by -122bps to 1.3% in 2023, then tumbled by -1926bps to 26.29% in 2024, then tumbled by -77bps to 46.55% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 46.55%, 2.57%, and 2.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.